UNSPSC 51191924: Ademetionine

This classification denotes an amino acid with the molecular formula C15H22N6O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7LP2MPO46S, chemically known as methionine, s-adenosyl- (6ci) active methionine but generally known as ademetionine, which bears US NIH Compound Identifier 34755. European Medicines Agency schedules Ademetionine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05266MIG.

UNSPSC 51191924 Ademetionine, a Commodity code, does not align with the state and local procurement activity posted under it. The code nominally describes S-adenosylmethionine, a pharmaceutical compound used in dietary supplements and medical treatments, yet the recent opportunities tagged to this code involve sodium bisulfite for municipal water treatment and generic pharmaceuticals and over-the-counter products for state and local health facilities — neither of which is ademetionine. The mismatch suggests either a tagging error in the source systems or an outdated code assignment that no longer reflects current procurement intent under this category.

The two recent opportunities show activity across different issuing bodies and regions. The City of Meriden, Connecticut posted an IFB for sodium bisulfite chemical supply to its Water Pollution Control Facility with a response deadline of July 29, 2026, requiring bidders to carry general liability insurance of $1,000,000 to $2,000,000 and performance bonds. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities including Oregon, with proposals due March 26, 2026 and contract awards effective July 1, 2026. Given the absence of procurement activity actually aligned with ademetionine as a product line and the limited recent opportunities under this code, pursuit activity should focus on clarifying the code's intended scope with issuing bodies before investing in bid preparation or market analysis.